Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis
Abstract The cell adhesion molecule P‐selectin plays a key role in the pathogenesis of a vaso‐occlusive crisis (VOC) in patients with sickle cell disease (SCD). In the double‐blind, placebo‐controlled phase 2 SUSTAIN study, crizanlizumab (humanized, anti‐P‐selectin monoclonal antibody) 5 mg/kg signi...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | englanti |
| Julkaistu: |
2018
|
| Linkit: | https://doi.org/10.1002/ajh.25308 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.25308 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|